News in brief

Rexam opens extension at French nasal pump plant

Rexam opens extension at French nasal pump plant

Rexam has completed its extension of a French plant that manufactures the nasal spray pump product, Advancia.

Advancia is a drug delivery device that modulates accurate and consistent doses of a drug, even when the pump has not been used for several weeks, a Rexam spokesman told this publication in June 2006.

The product is set to be manufactured at Rexam’s Le Tréport facility in Normandy, France, following the completion and inauguration of a €20m ($27m) expansion yesterday that sees a new unit measuring 3,750 m² (including a new 2,900 m² clean room) added to the site, plus additional space to house maintenance workshops and a new metrology department.

The new year brings the arrival of the equipment we need to manufacture next generation products in the new facility,” said Stéphane Thiaudière, Plant Manager.

As well as the Advancia pump, the site makes other spray pumps and valves for export to more than one hundred countries.

Related News

Rexam Expands Normandy Plant; Ups Nasal Pump Manufacturing

Rexam Expands Normandy Plant; Ups Nasal Pump Manufacturing

Rexam expand insulin pen capacity

Lilly drives expansion at Rexam's insulin pen manufacturing plant

Pharma Packaging Market to Grow to $73B by 2018, Report Finds

Pharma Packaging Market to Grow to $73B by 2018, Report Finds

Lilly has invested over $1bn in insulin production over the last year

Lilly invests across all insulin sites in prep for diabetes epidemic

Lilly to expand insulin facility again

Lilly's Second Insulin Injection Brings Total to $240m Over 5 Months

Related Products

See more related products